| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701973 | Journal of Thoracic Oncology | 2017 | 20 Pages |
Abstract
The data presented in the current study support using PCI in patients with p-stage II/III disease but not in patients with p-stage I disease. A relatively lower risk for brain metastases in p-stage I patients might explain the inferior efficacy of PCI in this population.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jianlin MD, Haitang MD, Xiaolong MD, Bo MD, Yuqing MD, Yanwei PhD, Xueyan PhD, Hua PhD, Huimin MD, Dan MD, Baohui MD, PhD,